
               
               
               7 DRUG INTERACTIONS
               
               
                  
                     
                        
                           
                              Other opioid antagonists: Potential for additive effect and increased risk of opioid withdrawal; avoid concomitant use (7.1)
                        
                     
                  
               
               
                  
                     
                     
                     7.1  Other Opioid Anatagonists
                     
                        Avoid concomitant use of RELISTOR with other opioid antagonists because of the potential for additive effects of opioid receptor antagonism and increased risk of opioid withdrawal.
                     
                     
                  
               
               
                  
                     
                     
                     7.2 

Drugs Metabolized by Cytochrome P450 Isozymes
                     
                        In healthy subjects, a subcutaneous dose of 0.30 mg/kg of methylnaltrexone did not significantly affect the metabolism of dextromethorphan, a CYP2D6 substrate.  
                     
                     
                  
               
            
         